Emprumapimod (PF-07265803) hydrochloride is an orally active and selective inhibitor of p38alpha MAPK. Emprumapimod hydrochloride can be used for the research of dilated cardiomyopathy and acute inflammatory pain[1][2].
Molecular Weight:
509.98
Purity:
98
Formula:
C24H30ClF2N5O3
Target:
p38 MAPK
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
